AssociatedDiseases,Allele,Position,RNA
MELAS / MM & EXIT,m.583G>A,583,tRNA Phe
Gitelman-like syndrome,m.591C>T,591,tRNA Phe
Maternally inherited epilepsy / mito tubulointerstitial kidney disease (MITKD) / Gitelman-like syndrome,m.616T>C,616,tRNA Phe
DEAF,m.1494C>T,1494,12S rRNA
DEAF; autism spectrum intellectual disability; possibly antiatherosclerotic,m.1555A>G,1555,12S rRNA
AMDF,m.1606G>A,1606,tRNA Val
Leigh Syndrome,m.1624C>T,1624,tRNA Val
MNGIE-like disease / MELAS,m.1630A>G,1630,tRNA Val
Leigh Syndrome / HCM / MELAS,m.1644G>A,1644,tRNA Val
MM / HCM+renal tubular dysfunction,m.3242G>A,3242,tRNA Leu (UUR)
MELAS / Leigh Syndrome / DMDF / MIDD / SNHL / CPEO / MM / FSGS / ASD / Cardiac+multi-organ dysfunction,m.3243A>G,3243,tRNA Leu (UUR)
MM / MELAS / SNHL / CPEO,m.3243A>T,3243,tRNA Leu (UUR)
MM / MELAS with chorea-ballism,m.3251A>G,3251,tRNA Leu (UUR)
MELAS,m.3252A>G,3252,tRNA Leu (UUR)
MERRF / KSS overlap,m.3255G>A,3255,tRNA Leu (UUR)
MELAS; possible atherosclerosis risk,m.3256C>T,3256,tRNA Leu (UUR)
MELAS / Myopathy,m.3258T>C,3258,tRNA Leu (UUR)
MMC / MELAS,m.3260A>G,3260,tRNA Leu (UUR)
MELAS / DM / MERRF-like,m.3271T>C,3271,tRNA Leu (UUR)
PEM / retinal dystrophy in MELAS,m.3273delT,3273,tRNA Leu (UUR)
Myopathy,m.3280A>G,3280,tRNA Leu (UUR)
MELAS / Myopathy / Deafness+Cognitive Impairment,m.3291T>C,3291,tRNA Leu (UUR)
MM,m.3302A>G,3302,tRNA Leu (UUR)
MMC,m.3303C>T,3303,tRNA Leu (UUR)
LHON MELAS overlap,m.3376G>A,3376,E24K
LHON,m.3460G>A,3460,A52T
MELAS / Progressive Encephalomyopathy,m.3481G>A,3481,E59K
Mitochondrial myopathy with reversible cytochrome C oxidase deficiency,m.3571delC,3571,frameshift
LHON,m.3635G>A,3635,S110N
Leigh Syndrome,m.3688G>A,3688,A128T
MELAS / Leigh Syndrome / LDYT / BSN,m.3697G>A,3697,G131S
LHON,m.3700G>A,3700,A132T
LHON,m.3733G>A,3733,E143K
Progressive Encephalomyopathy / Leigh Syndrome / Optic Atrophy,m.3890G>A,3890,R195Q
EXIT+myalgia / severe LA+cardiac / 3-MGA aciduria / nephropathy+deafness+diabetes,m.3902_3908ACCTTGCinv,3902,DLA-GKV
MELAS,m.3946G>A,3946,E214K
LHON / Leigh-like phenotype,m.4171C>A,4171,L289M
CPEO / MS,m.4298G>A,4298,tRNA Ile
MICM,m.4300A>G,4300,tRNA Ile
CPEO,m.4308G>A,4308,tRNA Ile
Encephalopathy / MELAS,m.4332G>A,4332,tRNA Gln
Myopathy / MELAS / Leigh Syndrome / EXIT,m.4450G>A,4450,tRNA Met
EXIT with myalgia & ophthalmoplegia,m.4810G>A,4810,W114Term
Mitochondrial myopathy,m.5521G>A,5521,tRNA Trp
Leigh Syndrome,m.5537_5538insT,5537,tRNA Trp
Combined OXPHOS defects,m.5556G>A,5556,tRNA Trp
Myopathy,m.5650G>A,5650,tRNA Ala
CPEO+ptosis+proximal myopathy,m.5690A>G,5690,tRNA Asn
CPEO / MM,m.5703G>A,5703,tRNA Asn
Multiorgan failure / myopathy,m.5728T>C,5728,tRNA Asn
Myoglobinuria / EXIT,m.5920G>A,5920,W6Term
Multisystem Disorder,m.6930G>A,6930,G343Term
SNHL,m.7445A>G,7445,Term514Term/ tRNA Ser (UCN) precursor
Fatal neonatal lactic acidosis / Neonatal lactic acidosis; exercise intolerance; mild ID,m.7453G>A,7453,tRNA Ser (UCN)
PEM / AMDF / Motor neuron disease-like,m.7471_7472insC,7471,tRNA Ser (UCN)
MM / EXIT,m.7497G>A,7497,tRNA Ser (UCN)
SNHL,m.7510T>C,7510,tRNA Ser (UCN)
SNHL/Deafness,m.7511T>C,7511,tRNA Ser (UCN)
PEM / MERME  / MELAS,m.7512T>C,7512,tRNA Ser (UCN)
Mitochondrial Encephalomyopathy,m.7587T>C,7587,M1T
Multisystem Disorder,m.7896G>A,7896,W104Term
Mitochondrial myopathy with complex IV deficiency,m.8088delT,8088,frameshift
Severe adult-onset multisymptom myopathy / Myoclonic epilepsy,m.8306T>C,8306,tRNA Lys
MNGIE-like / Progressive mito cytopathy,m.8313G>A,8313,tRNA Lys
Myopathy; Exercise Intolerance; CPEO-like /childhood epilepsy with SNHL & eye disease,m.8340G>A,8340,tRNA Lys
MERRF; Other - LD / depressive mood disorder / leukoencephalopathy / HiCM / lipomas,m.8344A>G,8344,tRNA Lys
MERRF,m.8356T>C,8356,tRNA Lys
MICM+DEAF / MERRF / Autism / Leigh Syndrome / Ataxia,m.8363G>A,8363,tRNA Lys
Infantile cardiomyopathy / hyperammonemia,m.8528T>C,8528,ATP8:W55R ATP6:M1T
NARP/cognitive decline+abnormal brain MRI+impaired kidney function,m.8618_8619insT,8618,frameshift
BSN / Leigh syndrome,m.8851T>C,8851,W109R
Mitochondrial myopathy; lactic acidosis and sideroblastic anemia (MLASA) / IgG nephropathy,m.8969G>A,8969,S148N
NARP / Leigh Disease / MILS / other,m.8993T>C,8993,L156P
NARP / Leigh Disease / MILS / other,m.8993T>G,8993,L156R
Developmental delay & myopathy,m.8993TG>CA,8993,L156P
Ataxia syndromes,m.9035T>C,9035,L170P
MIDD; renal insufficiency,m.9155A>G,9155,Q210R
FBSN / Leigh Disease / Spinocerebellar Ataxia,m.9176T>C,9176,L217P
Leigh Disease / Spastic Paraplegia / Spinocerebellar Ataxia,m.9176T>G,9176,L217R
Leigh Disease / Ataxia syndromes / NARP-like disease / Episodic weakness and Charcot-Marie-Tooth,m.9185T>C,9185,L220P
Leigh Disease,m.9191T>C,9191,L222P
Encephalopathy / Seizures / Lacticacidemia,m.9205_9206delTA,9205,Term-M
Myoglobinuria,m.9480_9494delTTTTTCTTCGCAGGA,9480,FFFAG-del
Leigh Disease,m.9537_9538insC,9537,frameshift
Mitochondrial Encephalopathy,m.9952G>A,9952,W249Term
PEM,m.10010T>C,10010,tRNA Gly
Leigh Disease / MELAS,m.10158T>C,10158,S34P
Leigh Disease / ESOC,m.10191T>C,10191,S45P
Leigh Disease / Dystonia / Stroke / LDYT,m.10197G>A,10197,A47T
Leigh Disease,m.10254G>A,10254,D66N
LHON,m.10663T>C,10663,V65A
Leigh Disease,m.11777C>A,11777,R340S
LHON / Progressive Dystonia,m.11778G>A,11778,R340H
MERRF-MELAS / Encephalopathy,m.12147G>A,12147,tRNA His
Maternally inherited non-syndromic deafness,m.12201T>C,12201,tRNA His
DMDF / RP+SNHL,m.12258C>A,12258,tRNA Ser (AGY)
CPEO,m.12276G>A,12276,tRNA Leu (CUN)
CPEO / EXIT+Ophthalmoplegia,m.12294G>A,12294,tRNA Leu (CUN)
CPEO / KSS / possible carotid atherosclerosis risk; trend toward myocardial infarction risk,m.12315G>A,12315,tRNA Leu (CUN)
CPEO / mitochondrial myopathy,m.12316G>A,12316,tRNA Leu (CUN)
Mitochondrial myopathy & renal failure,m.12425delA,12425,frameshift
Leigh Disease,m.12706T>C,12706,F124L
Optic neuropathy/ retinopathy/ LD,m.13042G>A,13042,A236T
LHON,m.13051G>A,13051,G239S
Ataxia+PEO / MELAS; LD; LHON; myoclonus; fatigue,m.13094T>C,13094,V253A
LHON,m.13379A>G,13379,H348R
Leigh Disease / MELAS / LHON-MELAS Overlap Syndrome / negative association w Carotid Atherosclerosis,m.13513G>A,13513,D393N
Leigh Disease / MELAS / Ca2+ downregulation,m.13514A>G,13514,D393G
MELAS / Leigh Disease,m.14453G>A,14453,A74V
LDYT / Leigh Disease / dystonia / carotid atherosclerosis risk,m.14459G>A,14459,A72V
LHON,m.14482C>A,14482,M64I
LHON,m.14482C>G,14482,M64I
LHON,m.14484T>C,14484,M64V
Dystonia / Leigh Disease / ataxia / ptosis / epilepsy,m.14487T>C,14487,M63V
LHON,m.14495A>G,14495,L60S
EXIT w mild myopathy & hyperCKaemia,m.14512_14513delTA,14512,frameshift
LHON,m.14568C>T,14568,G36S
LHON / LS,m.14597A>G,14597,I26T
Reversible COX deficiency myopathy,m.14674T>C,14674,tRNA Glu
MM+DMDF / Encephalomyopathy / Dementia+diabetes+ophthalmoplegia,m.14709T>C,14709,tRNA Glu
Encephalomyopathy + Retinopathy,m.14710G>A,14710,tRNA Glu
PD / MELAS,m.14787_14790delTTAA,14787,frameshift
EXIT / Septo-Optic Dysplasia,m.14849T>C,14849,S35P
EXIT,m.15150G>A,15150,W135Term
Mitochondrial Encephalomyopathy,m.15242G>A,15242,G166Term
Multisystem Disorder; EXIT,m.15579A>G,15579,Y278C
LIMM / MERRF / mito disease,m.15923A>G,15923,tRNA Thr
MM / PEO,m.15990C>T,15990,tRNA Pro
